In Patient ID-18, amplifications of the CCND1 and ERBB2 genes were suspected in ctDNA and the genes were also clearly amplified in the primary cancer by aCGH analysis (Fig. 4A and Supplementary Figure S7). This evidence concerns the gene CCND1 and cancer.